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Guest [J. Gen. Microbial. (1981) 124, 17-231 has cloned the citrate synthase gene from E. coli into ColEi 
plasmids. This plasmid-coded enzyme has now been purified and characterised and shown to be 
indistinguishable from the chromosome-coded enzyme in molecular, catalytic and regulatory properties. 
The plasmid copy number has been raised to > 2OO/cell by treatment with chloramphenicol and the effects 
of this increase on the intracellular level of citrate synthase have been investigated. 
Citrate synthase Escherichia coli Plasmid 
1. INTRODUCTION 
Citrate synthase catalyses the introduction of 
acetyl-CoA into the citric acid cycle and may be an 
important site of control of this pathway [ 1,2]. The 
enzyme from Escherichia coli is allosterically in- 
hibited by NADH [3,4] and by cY-oxoglutarate 
[5,6] which are primary end-products of the cycle 
under aerobic and anaerobic growth conditions, 
respectively. It is a hexameric protein of identical 
subunits [7] and contrasts markedly with the 
dimeric enzymes from Gram-positive bacteria and 
eukaryotes, all of which are insensitive to the 
above allosteric effecters [1,2,8,9]. 
in the oligomeric and regulatory nature of the en- 
zyme. It was therefore essential to examine the en- 
zyme from the cloned gene to ascertain its reten- 
tion of the properties of the normal enzyme. In ad- 
dition, we have increased the plasmid copy number 
of one E. coli strain by taking advantage of the 
continued replication of ColEl plasmids when 
chromosomal replication is stopped by protein 
synthesis inhibitors. The effects of this increase on 
intracellular levels of citrate synthase are reported. 
2. EXPERIMENTAL 
2.1. Materials 
ColEl-E. coli hybrid plasmids containing the 
citrate synthase gene have been identified [lo]. 
Amplification of such plasmid copy numbers in E. 
coli should lead to greatly increased intracellular 
levels of citrate synthase, facilitating the isolation 
of the enzyme for detailed structural studies. 
However, we have shown [l ,l l] that only minor 
genetic alterations to the chromosomal citrate syn- 
thase gene of E. coli can lead to marked changes 
All chemicals used were analytical grade. The 
strain of E. coli used was JA200 (F+ thr leu lacy1 
trpAE.5 recAZ), kindly provided by Professor J.R. 
Guest (University of Sheffield). It contained 
several copies of a synthetic ColEl-E. coli hybrid 
plasmid designated pLC 26-17 incorporating the E. 
coli citrate synthase gene [lo]. 
2.2. Methods 
* To whom correspondence should be addressed 
The plasmid copy number of E. coli JA200 was 
increased by treatment of the cells with chloram- 
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phenicol according to [12]. Cells were grown 
aerobically at 37°C in L-broth [13] and chloram- 
phenicol was added to the culture in log phase 
(&se = 0.4) to 25 pug/ml final cont. The culture 
was shaken for 12 h after which the cells were 
twice washed free of chloramphenicol and re- 
suspended in fresh medium to the same cell density 
as that before the addition of the antibiotic. The 
cells were then grown aerobically at 37°C and 
harvested after one generation. The total DNA 
content of E. coli JA200, before and after treat- 
ment with chloramphenicol, was prepared as in 
[14]. Separation of the ColEl DNA from the 
chromosomal DNA was achieved by vertical gel 
electrophoresis on 1% agarose gel [15]. DNA was 
stained with ethidium bromide and the gel was 
photographed under UV light. 
Citrate synthase was assayed spec- 
trophotometrically at 412 nm [16]. The enzyme 
was purified from E. coli JA200 before plasmid 
amplification. Nucleic acid was removed from a 
French-press extract with protamine sulphate [ 171 
and the enzyme further purified by ion-exchange 
chromatography on DEAE-Sephacel using a 
linear (0.1-0.5 M) KC1 gradient. Purification was 
completed by chromatography on a column of 
Matrex Gel Red A (Amicon) with a O-O.5 M NaCl 
gradient. 
SDS-polyacrylamide gel electrophoresis and gel 
filtration in 6 M guanidine-HCl on Sephacryl 
S-300 were done as in [9]. Sedimentation velocity 
analysis was carried out in a Beckman LS-50B 
analytical ultracentrifuge and determination of 
Stokes’ radii by zonal gel filtration on Sephadex 
G-200 was performed as in [9]. Cross-linking of 
the enzyme with glutaraldehyde was according to 
PI * 
3. RESULTS 
3.1. Purification of citrate synthase 
The purification procedure is summarized in 
table 1. The specific activity of the enzyme in the 
French-press extract was -7-fold greater than that 
found in the E. coli strain lacking the plasmid, as 
in [IO]. This increase in the initial specific activity 
permitted the purification of the enzyme in high 
yield after only 3 stages (table 1). 
3.2. Molecular and kinetic properties of citrate 
syn thase 
In molecular and kinetic properties the citrate 
synthase purified from the plasmid-containing 
strain JA200 was indistinguishable from that ob- 
tained from a non-plasmid organism. 
In agreement with [7], the citrate synthase was 
shown to be a hexameric enzyme of which the con- 
stituent polypeptides are all of the same molecular 
size. Thus the enzyme sedimented as a single pro- 
tein species with sedimentation coefficient (s~zo,~) 
of 11.5 (f 0.3) S. Similarly on zonal gel filtration 
one protein peak was observed and by comparison 
of its elution volume with those of standard pro- 
teins of known molecular size (see [9] for the 
calibration curve) a Stokes’ radius of 5.6 (+ 0.1) x 
lo-’ cm was calculated. Taking the partial specific 
volume (0.73 ml/g) from the amino acid composi- 
tion, iW, 269000 (+ 6000) was determined. 
Table 1 
Purification of E. coli citrate synthase 
Step Vol. 
(ml) 
Total 
enzyme 
(units) 
Total Spec. act. Yield (@/o) 
protein (units/mg) 
(mg) 
1. French-press extract 
2. Supernatant from protamine sulphate 
3. Pooled, selected fractions from 
DEAE-Sephacel column 
4. Pooled, selected fractions from 
red gel A column 
58 5544 3793 1.5 - 
58 5288 3686 1.4 95 
50 5000 270 18.5 90 
8 2003 32 62.6 36 
A unit of enzymic activity is defined as that producing 1 pmol CoASH/min 
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One protein band was found on SDS-gel elec- 
trophoresis and on gel filtration in 
guanidine-HCl; polypeptide chain M-values of 
44000 (+ 2500) and 49000 (-t 2000) were 
estimated by these two methods. These values, 
taken with that of the native citrate synthase, give 
5.8 (f 0.4) polypeptides/enzyme molecule. This 
hexameric structure was confirmed by SDS gel 
electrophoresis of the enzyme after cross-linking 
with glutaraldehyde; 6 protein bands were observ- 
ed. No more than 6 bands were generated even 
after extensive modification. 
The citrate synthase showed a sigmoidal 
dependence of velocity on both acetyl-CoA and 
oxaloacetate concentrations as reported for the en- 
zyme from a non-plasmid strain [ 181. Similarly, 
enzymic activity was inhibited by NADH and a- 
oxoglutarate in a manner indistinguishable from 
that observed with the chromosome-coded citrate 
synthase (fig.1) and was insensitive to ATP. 
3.3. Amplification of plasmid copy number 
The continued replication of ColEl plasmids in 
the presence of chloramphenicol [12] was used to 
increase the plasmid copy number of E. coli 
JA200. DNA was isolated and electrophoresed as 
in section 2. Photographic negatives of the gels 
stained with ethidium bromide were scanned in a 
0 10 20 30 40 50 
[NADHI (!.IM) 
recording densitometer. It was found that the ab- 
sorbance ratio of plasmid to chromosomal DNA 
after chloramphenicol treatment was -30-times 
greater than that from untreated cells grown under 
otherwise identical conditions. Assuming that 
JA200 originally contained 7-10 copies of the 
plasmid/cell ([lo] and section 3.1 above) the 
chloramphenicol treatment appears to have in- 
creased this to 200-300 copies. 
3.4. Intracellular levels of citrate synthase 
Surprisingly, the specific activity of citrate syn- 
thase in cells with the plasmid copy number 
amplified by chloramphenicol treatment was only 
4 units/mg protein, a rise of 2.7-fold over cells 
with just 7-10 copies of plasmid. Incubation of 
cells in different concentrations of chloram- 
phenicol (25-200 pg/ml) did not improve on this 
specific activity. Resuspension of treated cells in 
amino acid-supplemented media also had no ef- 
fect, although the citrate synthase activity was in- 
creased by 30% in both acetate and acetate/aspar- 
tate minimal media whereas it was decreased by 
25% in glucose minimal medium. When L-broth 
was supplemented with 1 Vo glucose the specific ac- 
tivity of the enzyme decreased to 0.1 units/mg pro- 
tein, a value < 10% of the original JA200 strain. 
0 0.5 1-O 1.5 2.0 
[a-OXOGLUTARATEI (MM) 
Fig.1. Inhibition of plasmid-coded (0) and chromosome-coded (0) E. coli citrate synthase activity by NADH (A) and 
a-oxoglutarate (B). Citrate synthase was assayed spectrophotometrically at 412 nm [16] using 0.15 mM acetyl-CoA and 
0.05 mM oxaloacetate. 
53 
Volume 154, number 1 FEBS LETTERS April 1983 
4. DISCUSSION ACKNOWLEDGEMENTS 
This study aimed to characterise the product of 
the plasmid-cloned gene E. coli citrate synthase 
(lo] and to increase the plasmid copy number to 
facilitate purification of large amounts of the 
enzyme. 
We have demonstrated that the cloning [IO] has 
been achieved without any apparent modification 
of the gene, the enzyme produced being in- 
distinguishable from the chromosome-coded en- 
zyme in molecular, kinetic and regulatory proper- 
ties. Additionally, we have achieved considerable 
amplification of the cloned gene dosage (up to 
2~-3~ copies/cell) though this was not matched 
by a corresponding increase in the intracellular 
levels of enzyme. The maximum specific activity 
achieved (-5 units/mg protein) is 25times the level 
found in non-plasmid strains. Intracellular levels 
of other enzymes (e.g., NADH dehydrogenase 
[12]) cloned into plasmids have been amplified to 
considerably greater extents than that found here 
for citrate synthase, suggesting that in the present 
study the capacity for transcription or translation 
is not a limitation. Rather it is likely that the cell 
can still regulate its level of the cloned citrate syn- 
thase. Support for this is gained from growth on 
glucose after plasmid amplification when synthesis 
of citrate synthase was reduced to levels ap- 
proaching that of the non-plasmid organism. 
We thank Professor John R. Guest for kindly 
providing the plasmid-cont~ning strain of E. co/i 
and for helpful discussions, and Dr Janet A. Pryke 
for assistance with the isolation and analysis of 
DNA. Support from the Science and Engineering 
Research Council (grant GR/B/lO441) is grateful- 
ly acknowledged. 
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